IXOS Radius Plate System

K171624 · Stuckenbrock Medizintechnik GmbH · HRS · Mar 29, 2018 · Orthopedic

Device Facts

• Record ID: K171624
• Device Name: IXOS Radius Plate System
• Applicant: Stuckenbrock Medizintechnik GmbH
• Product Code: HRS · Orthopedic
• Decision Date: Mar 29, 2018
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The IXOS Radius Plate System is intended for surgical procedures in which internal fixation by implants is required for aligning, reconstruction and stabilizing bone tissue. It is used in particular for fixing intra- and extra articular acute fractures of the distal radius, in particularly - · Type A2 Colles fractures - · Type A3 fractures - · Type B1 fractures - · Type B2 Barton fractures - · Type B3 Smith or reversed Barton fractures - · Type C1 fractures - · Type C2 fractures - · Type C3 fractures and in osteotomies of the distal radius.

Device Story

IXOS Radius Plate System consists of metallic bone fixation plates and screws; used for internal fixation, alignment, reconstruction, and stabilization of distal radius fractures and osteotomies. Device utilized in surgical settings by orthopedic or hand surgeons. Implants provide mechanical support to bone tissue during healing. System design, materials, and intended use are analogous to existing market-cleared fixation systems. Clinical benefit derived from stabilization of fractures to facilitate bone union.

Clinical Evidence

Bench testing only. Static and dynamic 4-point bending tests performed on the device and predicate. Screws tested per ASTM F543-13. Biocompatibility testing performed to confirm biological safety.

Technological Characteristics

Metallic bone fixation plates and screws. Testing conducted per ASTM F543-13 for screws. Mechanical performance validated via static and dynamic 4-point bending tests. No software or electronic components.

Indications for Use

Indicated for patients requiring internal fixation for alignment, reconstruction, and stabilization of bone tissue, specifically for acute intra- and extra-articular distal radius fractures (Types A2, A3, B1, B2, B3, C1, C2, C3) and distal radius osteotomies.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• APTUS® Titanium Fixation System (K051567)

Reference Devices

• Zimmer Distal Radius Plating System (K133246)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text.

March 29, 2018

Stuckenbrock Medizintechnik GmbH Fabian Stuckenbrock President of Stuckenbrock Medizintechnik Lessingstraße 50 Tuttlingen, Baden-Wurttemberg, Germany 78532

Re: K171624

Trade/Device Name: IXOS Radius Plate System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS Dated: February 19, 2018 Received: February 22, 2018

Dear Fabian Stuckenbrock:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

# Vincent J. Devlin -S

for

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

#### Indications for Use

510(k) Number (if known)

K171624

Device Name

IXOS Radius Plate System

Indications for Use (Describe)

The IXOS Radius Plate System is intended for surgical procedures in which internal fixation by implants is required for aligning, reconstruction and stabilizing bone tissue.

It is used in particular for fixing intra- and extra articular acute fractures of the distal radius, in particularly

- · Type A2 Colles fractures
- · Type A3 fractures
- · Type B1 fractures
- · Type B2 Barton fractures
- · Type B3 Smith or reversed Barton fractures
- · Type C1 fractures
- · Type C2 fractures
- · Type C3 fractures

and in osteotomies of the distal radius.

Type of Use (Select one or both, as applicable)

> Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

K171624

#### DATE OF APPLICATION: 22.05.2017

APPLICANT:

Stuckenbrock Medizintechnik GmbH: Lessingstraße 50 78532 Tuttlingen Germany Tel: + 49 (0)7461/165880 Fax: [phone] E-Mail: [e-mail] Internet: www.stuckenbrock.de

| CONTACT PERSON: | Fabian Stuckenbrock<br>President of Stuckenbrock Medizintechnik GmbH<br>Tel.: [phone]<br>E-Mail: [e-mail] |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------|
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------|

{4}------------------------------------------------

# Stuckenbrock Medizintechnik ein Unternehmen der KLS MOI CIN Group

#### 1. Device Name

| Trade Name: | IXOS Radius Plate System |
|-----------------------------|--------------------------------------------------------------------------------|
| Common Name: | Bone fixation plate |
| Device Classification Name: | Single/multiple component metallic bone<br>fixation appliances and accessories |

# 2. Classification / Product Code

Stuckenbrock IXOS Radius Plate System can be classified according to following device name and product code:

| Device | Regulation<br>Description | Regulation<br>Medical<br>Specialty | Review<br>Panel | Product<br>Code | Regulation<br>Number | Device<br>Classificatio<br>n |
|--------------------------|-----------------------------------------------------------------------------------------|------------------------------------|-----------------|-----------------|----------------------|------------------------------|
| Plate, Fixation,<br>Bone | Single/multiple<br>component metallic<br>bone fixation<br>appliances and<br>accessories | Orthopedic | Orthopedic | HRS | 888.3030 | 2 |

### 3. Predicate Device / Reference Device

| Device | Predicate Device | Reference Device | 510(k)<br>Number | 510(k) Holder |
|-----------------------------|------------------------------------|----------------------------------------|------------------|----------------|
| IXOS Radius Plate<br>System | APTUS® Titanium<br>Fixation System | - | K051567 | Medartis, Inc. |
| | - | Zimmer Distal Radius<br>Plating System | K133246 | Zimmer, Inc. |

#### 4. Device Description

The IXOS Radius Plate System is used for aligning, reconstructing and stabilizing bone tissue. It is used in the field of hand, accident and reconstructive surgery and orthopedics especially for the fixation of acute distal intra- and extra-articular fractures of the radius.

#### 5. Indication for Use

The IXOS Radius Plate System is intended for surgical procedures in which internal fixation by implants is required for aligning, reconstructing and stabilizing bone tissue.

It is used in particular for fixing intra- and extra-articular acute fractures of the distal radius, particularly

- . Type A2 Colles fractures
- Type A3 fractures ●
- Type B1 fractures
- Type B2 Barton fractures
- Type B3 Smith or reversed Barton fractures ●
- Type C1 fractures .

{5}------------------------------------------------

Stuckenbrock Medizintechnik ein Unternehmen der KLS MOITEIN Group

- Type C2 fractures ●
- Type C3 fractures ●

and in osteotomies of the distal radius

#### 6. Equivalence to Marketed Product

The IXOS Radius Plate System is substantially equivalent to the already marketed predicate devices APTUS Titanium Fixation System (K051567) and Zimmer Distal Radius Plating System (K133246). The IXOS Radius Plate System is substantially equivalent in intended use, material, size and design.

#### 7. Testing

Testing in order to proof safety and effectiveness of IXOS Radius Plate System has been performed according to recognized consensus standards and results are conforming to the respective requirements.

A static 4-point bending test as well as a dynamic 4-point bending test has been conducted with the IXOS Radius Plate System. IXOS screws have been tested according to ASTM F543-13. To compare the new device with the predicate device, the same tests were conducted for the predicate device. The comparison of the results shows that the new device IXOS Radius Plate System is substantially equivalent to the predicate device.

#### 8. Biocompatibility

The IXOS Radius Plate System has been evaluated for its biological safety. Tests have been performed to proof the biocompatibility of the device.

#### 9. Substantial Equivalence Summary / Conclusion

Based on available 510(k) information provided herein, Stuckenbrock IXOS Radius Plate System is considered to be substantially equivalent to the predicate device in terms if indication for use, material, technology, design and performance specifications. There are no differences between the devices which would raise new issues of safety or effectiveness.